In 2024, several research and pharmacological advancements were made for tardive dyskinesia, a movement disorder caused by dopamine-blocking medications. Below are some of the highlights of the year.

Currently there are two FDA approved treatment options for tardive dyskinesia. There are two medications that are VMAT2 inhibitors. These are valbenazine (Ingrezza) and deutetrabenazine (Austedo) made ...

New draft guidelines on the definition of new active substances don’t apply to deutetrabenazine, the European drug regulator ...

After 5 weeks of taking 300 mg of lithium daily, a 76-year-old woman with lurasidone-induced tardive dyskinesia from treatment for Bipolar II Disorder experienced reduced impact, intensity, and ...

This was a prospective cohort study examining the incidence rate of tardive dyskinesia (TD) among 352 outpatients receiving atypical and/or typical antipsychotic medications at a community mental ...

The term "tardive syndrome" encompasses types of tardive dyskinesia, and using both when applicable can improve clarity in medical communication and literature. Tardive dyskinesia (TD) is widely known ...

TEL AVIV, Israel, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that a new analysis from the European cohort of the RIM-TD open-label ...

—According to new research, oral vertical dyskinesia (OVD), also known by the older term “rabbit syndrome,” may be part of a spectrum of symptoms of drug-induced parkinsonism and tardive dyskinesia, ...

Learn about tardive dyskinesia symptoms, causes, diagnosis, treatment options, and chances of remission with expert guidance and timely intervention.

Tardive dyskinesia, or TD, is a drug-induced movement disorder that can occur in individuals taking certain medications that block dopamine receptors in the brain. Most commonly, cases of TD are ...

Carnie Wilson, daughter of the late Beach Boys icon Brian Wilson, lends her voice to a campaign raising awareness of tardive dyskinesia. Few outside the mental health field have heard of tardive ...

This week, valbenazine became the first-ever drug approved by the Food and Drug Administration (FDA) for the treatment of tardive dyskinesia. Today, Psych Unseen answers some questions about the ...